Biocon And Viatris Ready To Launch EU Bevacizumab

Biocon Biologics Announces Formal EU Approval For Abevmy Biosimilar

EU Europe Flag Biosimilar Vaccine
Biocon and Viatris have received formal EU approval for Abevmy • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products